Posts

News
bg
Samty Holdings buys majority stake of Australia's UniLodge

Samty Holdings buys majority stake of Australia's UniLodge

The Japanese accommodation developer and fund manager has agreed to acquire a majority...

News
bg
Samty Holdings buys majority stake of Australia's UniLodge

Samty Holdings buys majority stake of Australia's UniLodge

The Japanese accommodation developer and fund manager has agreed to acquire a majority...

Classifields ads
bg
China property data delayed amid drop in Vanke bond prices

China property data delayed amid drop in Vanke bond prices

The Chinese property giant's debt woes will not seriously affect China’s property...

Classifields ads
bg
China property data delayed amid drop in Vanke bond prices

China property data delayed amid drop in Vanke bond prices

The Chinese property giant's debt woes will not seriously affect China’s property...

Classifields ads
bg
China property data delayed amid drop in Vanke bond prices

China property data delayed amid drop in Vanke bond prices

The Chinese property giant's debt woes will not seriously affect China’s property...

Classifields ads
bg
Andrew Cross joins Saudi Arabia’s National Development Fund as CFO

Andrew Cross joins Saudi Arabia’s National Development...

Cross was most recently chief financial officer at the Asian Infrastructure Investment...

Classifields ads
bg
Andrew Cross joins Saudi Arabia’s National Development Fund as CFO

Andrew Cross joins Saudi Arabia’s National Development...

Cross was most recently chief financial officer at the Asian Infrastructure Investment...

Classifields ads
bg
Andrew Cross joins Saudi Arabia’s National Development Fund as CFO

Andrew Cross joins Saudi Arabia’s National Development...

Cross was most recently chief financial officer at the Asian Infrastructure Investment...

Classifields ads
bg
Fosun Pharma subsidiary signs potential $1.9bn Pfizer licence deal

Fosun Pharma subsidiary signs potential $1.9bn Pfizer licence...

YP05002, developed by Yao Pharma, is in Phase 1 clinical development in Australia...

Classifields ads
bg
Fosun Pharma subsidiary signs potential $1.9bn Pfizer licence deal

Fosun Pharma subsidiary signs potential $1.9bn Pfizer licence...

YP05002, developed by Yao Pharma, is in Phase 1 clinical development in Australia...

Test